drugset
drugset / Trial / NCT02065739

A Study to Investigate the Effects of Itraconazole on the Pharmacokinetics of JNJ-42165279 in Healthy Male Participants

NCT02065739 ↗

Phase 1 Completed 16 enrolled Janssen Pharmaceutica N.V., Belgium
Non-randomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the effects of repeated administration of 200 mg of itraconazole on the single-dose pharmacokinetics of JNJ-42165279 in healthy male participants.

Timeline

Start
2014-01
Primary completion
2014-03
Completion
2014-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule 200 mg Oral
Subject JNJ-42165279 Small molecule 30 mg Oral

Indications

No indication recorded.